Kythera Biopharamaceuticals
Download our corporate fact sheet
Careers  |  Contact Us
  • Home
  • About
  • Pipeline
  • Our Team
  • Investors
  • Newsroom
About
  • Our Story
  • Board of Directors
  • Company Advisors
  • Collaborative Partners
  • Values
Pipeline
  • Overview
  • ATX-101
Investors
  • Overview
  • Earnings Releases
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Events & Presentations
  • Analyst Coverage
  • Investor FAQs
  • Contact Us
Newsroom
  • Press Releases
  • Media Coverage

Newsroom

  • Press Releases
    • Current
    • 2013 Archive
    • 2012 Archive
    • 2011 Archive
    • 2010 Archive
    • 2009 Archive
    • 2008 Archive
    • 2007 Archive
    • 2006 Archive
    • Media Coverage »

Kythera Newsroom

2008 Archive

October 20, 2008
KYTHERA Biopharmaceuticals To Participate In Investor Roundtable Hosted By Leerink Swann And The American Society Of Plastic Surgeons

June 8, 2008
KYTHERA Biopharmaceuticals To Participate In The Private Company Forum At The 29th Annual Goldman Sachs Global Healthcare Conference

May 19, 2008
KYTHERA Biopharmaceuticals Announces $40M Financing — Series C Round Led By JAFCO

April 15, 2008
KYTHERA Biopharmaceuticals Announces Second Phase II Clinical Trial With Adipolytic Agent For Reduction Of Submental Fat

February 14, 2008
KYTHERA has named Joseph L. Turner to its Board of Directors

View Pipeline »
Hide
Submental Fat Reduction »
Home | About | Pipeline | Our Team | Investors | Newsroom | Careers | Contact Us | Site Map
© 2013 Kythera Biopharmaceuticals, Inc. | Website by RBD